honokiol has been researched along with Lupus Nephritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fan, Y; Huang, S; Jing, X; Lou, J; Ma, Q; Qiu, J; Qiu, P; Xu, M; Yan, H; Yin, L; Zhao, L | 1 |
Chen, A; Hsu, WH; Hua, KF; Ka, SM; Liu, FC; Shang, HS; Wu, CY; Yang, SR | 1 |
2 other study(ies) available for honokiol and Lupus Nephritis
Article | Year |
---|---|
Honokiol suppresses the aberrant interactions between renal resident macrophages and tubular epithelial cells in lupus nephritis through the NLRP3/IL-33/ST2 axis.
Topics: Animals; Epithelial Cells; Inflammasomes; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Kidney; Lupus Nephritis; Macrophages; Mice; Mice, Inbred MRL lpr; Molecular Docking Simulation; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Receptors, Interleukin-1 | 2023 |
Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating NF-κB/NLRP3 inflammasome and sirtuin 1/autophagy axis.
Topics: Animals; Anti-Inflammatory Agents; Autophagy; Biphenyl Compounds; Cells, Cultured; Female; Inflammasomes; Kidney; Lignans; Lupus Nephritis; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Sirtuin 1; T-Lymphocytes | 2020 |